Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home

International Journal of Medical Sciences And Clinical Research

Peer Reviewed | Open Access | E-ISSN: 2771-2265
Published Article

Pathogenetic Mechanisms And Clinical Manifestations Of Cardiac Inficiency With Normal Systolic Function Of The Left Ventricle (Analytical Review)

Pathogenetic Mechanisms And Clinical Manifestations Of Cardiac Inficiency With Normal Systolic Function Of The Left Ventricle (Analytical Review)

  • Kurbanova Shohista Tojiddin qizi
    Tashkent State Medical University, Uzbekistan
Chronic heart failure preserved ejection fraction diastolic dysfunction HFpEF

Left ventricular diastolic dysfunction remains the central link in HFpEF pathogenesis, including slowed active myocardial relaxation and decreased heart chamber flexibility. The molecular mechanisms of diastolic dysfunction include cardiomyocyte calcium homeostasis disorders, changes in titin properties, fibrous changes in the myocardium, and energy metabolism disorders. These processes lead to an increase in left ventricular filling pressure and the development of clinical manifestations of congestive heart failure while maintaining normal myocardial contractility.

Borel K.N., Koziolova N.A. Heart failure with preserved ejection fraction: modern concepts of pathogenesis, diagnosis and treatment // Cardiology. - 2019. - Vol. 59, No. 4. - P. 74-82.

Vasyuk Yu.A., Shkolnik E.L., Nesukay E.G. Heart failure with preserved left ventricular ejection fraction: pathophysiology, diagnosis, treatment // Cardiology. - 2020. - Vol. 60, No. 3. - P. 129-139.

Mareev V.Yu., Fomin I.V., Ageev F.T. et al. Clinical recommendations for OSSN - RKO - RNMOT. Heart failure: chronic (CHF) and acute decompensated (ADF). Diagnosis, Prevention, and Treatment // Cardiology. - 2018. - Vol. 58, No. 6S. - P. 8-158.

Ponikowski P., Voors A.A., Anker S.D., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // Eur Heart J. - 2016. - Vol. 37, No. 27. - P. 2129-2200.

Borlaug B.A. Pathophysiology of heart failure with preserved ejection fraction // Nat Rev Cardiol. - 2014. - Vol. 11, No. 9. - P. 507-515.

Shah K.S., Xu H., Matsuaka R.A. et al. Heart failure with preserved, borderline, and reduced ejection fraction: results for 5 years // J Am Coll Cardiol. - 2017. - Vol. 70, No. 20. - P. 2476-2486.

Nagueh S.F., Smiseth O.A., Appleton C.P. et al. Recommendations for assessing left ventricular diastolic function by echocardiography: Update from the American Society of Echocardiography // J Am Soc Echocardiogr. - 2016. - Vol. 29, No. 4. - P. 277-314.

McDonagh T.A., Metra M., Adamo M., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // Eur Heart J. - 2021. - Vol. 42, No. 36. - P. 3599-3726.

Piske B., Chope C., de Boer R.A. et al. How to diagnose heart failure with preserved ejection fraction: HFA-PEFF diagnostic algorithm // Eur Heart J. - 2019. - Vol. 40, No. 40. - P. 3297-3317.

Duplyakov D.V., Yemelyanenko V.M., Svirida O.N. Heart failure with preserved ejection fraction: features of pathogenesis and therapeutic possibilities // Rational pharmacotherapy in cardiology. - 2020. - Vol. 16, No. 1. - P. 78-85.